• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量甲氧苄啶-磺胺甲恶唑和达托霉素作为治疗伴有大赘生物并并发栓塞性中风的耐甲氧西林金黄色葡萄球菌心内膜炎的一种治疗选择:病例报告及文献综述

High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review.

作者信息

Di Carlo Paola, D'Alessandro Natale, Guadagnino Giuliana, Bonura Celestino, Mammina Caterina, Lunetta Monica, Novo Salvatore, Giarratano Antonino

机构信息

Department of Sciences for Health Promotion G. D'Alessandro, University Hospital P. Giaccone, Palermo, Italy.

出版信息

Infez Med. 2013 Mar;21(1):45-9.

PMID:23524901
Abstract

Large cardiac vegetation carries a poor prognosis and high mortality risk, especially if associated with methicillin-resistant Staphylococcus aureus (MRSA) infection. We share our experience of a rare and complicated large cardiac vegetation which had a favourable outcome with combination antibiotic treatment alone. A 35-year-old HIV-negative, HCV-positive male patient with a previous history of methicillin-susceptible S. aureus endocarditis showed MRSA mitral valve endocarditis with large vegetation, complicated by embolic stroke. The strain was soon identified by PCR but only after culture did the patient receive efficacious antibiotics. A combination of daptomycin plus trimethoprim/sulfamethoxazole (TMP/SMX) was administered for six weeks, followed by a high dosage of TMP/SMX for a further six weeks. Effectiveness of the treatment was demonstrated by the patient's clinical improvement and instrumental evidence of cardiac mitral vegetation clearance. Innovative antibiotic strategies in patient management are needed to fight Staphylococcus aureus endocarditis because strains show varying antimicrobial susceptibility patterns in different geographic areas. Timely initiation of targeted antimicrobial therapy remains a crucial step to reduce morbidity and mortality but culture is crucial for appropriate fine-tuning of antibiotic therapy.

摘要

巨大心脏赘生物预后较差且死亡风险高,尤其是与耐甲氧西林金黄色葡萄球菌(MRSA)感染相关时。我们分享一例罕见且复杂的巨大心脏赘生物病例的经验,该病例仅通过联合抗生素治疗就取得了良好疗效。一名35岁的HIV阴性、HCV阳性男性患者,既往有甲氧西林敏感金黄色葡萄球菌性心内膜炎病史,现表现为MRSA二尖瓣心内膜炎伴巨大赘生物,并并发栓塞性中风。该菌株很快通过PCR鉴定出来,但患者在培养后才接受有效的抗生素治疗。给予达托霉素联合甲氧苄啶/磺胺甲恶唑(TMP/SMX)治疗6周,随后高剂量TMP/SMX再治疗6周。患者的临床改善以及心脏二尖瓣赘生物清除的影像学证据证明了治疗的有效性。由于不同地理区域的菌株表现出不同的抗菌药敏模式,因此在患者管理中需要创新的抗生素策略来对抗金黄色葡萄球菌性心内膜炎。及时开始针对性抗菌治疗仍然是降低发病率和死亡率的关键步骤,但培养对于抗生素治疗的适当微调至关重要。

相似文献

1
High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review.大剂量甲氧苄啶-磺胺甲恶唑和达托霉素作为治疗伴有大赘生物并并发栓塞性中风的耐甲氧西林金黄色葡萄球菌心内膜炎的一种治疗选择:病例报告及文献综述
Infez Med. 2013 Mar;21(1):45-9.
2
Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.达托霉素与甲氧苄啶-磺胺甲恶唑联合使用对耐甲氧西林金黄色葡萄球菌感染临床结局的影响。
Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.
3
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.以最低抑菌浓度 2 μg/mL 治疗耐甲氧西林金黄色葡萄球菌感染:旧药(复方磺胺甲噁唑)与新药(达托霉素或利奈唑胺)的比较。
Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4.
4
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.评价高剂量达托霉素联合复方磺胺甲噁唑治疗耐甲氧西林金黄色葡萄球菌(MRSA)感染的新型组合,该组合采用模拟心内膜赘生物的体外药代动力学/药效学模型。
Antimicrob Agents Chemother. 2012 Nov;56(11):5709-14. doi: 10.1128/AAC.01185-12. Epub 2012 Aug 20.
5
Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.用甲氧苄啶-磺胺甲恶唑和抑制细胞壁合成的抗生素治疗由甲氧西林敏感或耐甲氧西林金黄色葡萄球菌引起的实验性心内膜炎。
Antimicrob Agents Chemother. 1995 Apr;39(4):953-7. doi: 10.1128/AAC.39.4.953.
6
Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.用达托霉素治疗的耐甲氧西林金黄色葡萄球菌人工主动脉瓣心内膜炎合并瓣周脓肿
Heart Lung. 2005 Jan-Feb;34(1):69-71. doi: 10.1016/j.hrtlng.2004.07.009.
7
Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).万古霉素治疗耐甲氧西林金黄色葡萄球菌(MRSA)二尖瓣急性细菌性心内膜炎(ABE)后出现的达托霉素耐药与治疗失败。
Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):831-3. doi: 10.1007/s10096-008-0692-2. Epub 2009 Jan 28.
8
Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.采用达托霉素和利奈唑胺治疗三尖瓣心内膜炎。
Am J Health Syst Pharm. 2019 Jul 2;76(14):1033-1036. doi: 10.1093/ajhp/zxz101.
9
Clinical management of Staphylococcus aureus bacteremia: a review.金黄色葡萄球菌菌血症的临床管理:综述。
JAMA. 2014 Oct 1;312(13):1330-41. doi: 10.1001/jama.2014.9743.
10
In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.治疗耐甲氧西林金黄色葡萄球菌心内膜炎期间体内获得的达托霉素耐药性。
Int J Infect Dis. 2013 Nov;17(11):e1076-7. doi: 10.1016/j.ijid.2013.02.019. Epub 2013 Apr 9.

引用本文的文献

1
Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series.达托霉素嗜酸性粒细胞性肺炎:文献系统评价与病例系列研究
Infection. 2024 Dec;52(6):2145-2168. doi: 10.1007/s15010-024-02349-z. Epub 2024 Jul 19.
2
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy.耐甲氧西林金黄色葡萄球菌中万古霉素和达托霉素敏感性的不断下降——用联合疗法挽救金标准
Antibiotics (Basel). 2020 Oct 30;9(11):762. doi: 10.3390/antibiotics9110762.
3
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
金黄色葡萄球菌感染:流行病学、病理生理学、临床表现及管理
Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14.
4
Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.达托霉素与甲氧苄啶-磺胺甲恶唑联合使用对耐甲氧西林金黄色葡萄球菌感染临床结局的影响。
Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.
5
A new strategy to fight antimicrobial resistance: the revival of old antibiotics.对抗抗菌素耐药性的新策略:旧抗生素的复兴。
Front Microbiol. 2014 Oct 20;5:551. doi: 10.3389/fmicb.2014.00551. eCollection 2014.
6
High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.高剂量达托霉素治疗葡萄球菌心内膜炎及其应用时机。
Curr Infect Dis Rep. 2014 Oct;16(10):429. doi: 10.1007/s11908-014-0429-6.
7
Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve Methicillin-Resistant Staphylococcus aureus Endocarditis.达托霉素治疗天然三尖瓣和二尖瓣耐甲氧西林金黄色葡萄球菌心内膜炎合并肺脓毒性栓子失败
Case Rep Infect Dis. 2013;2013:653582. doi: 10.1155/2013/653582. Epub 2013 Nov 25.